Ribociclib

Major

Ribociclib Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Ribociclib Abametapir Explained Increased exposure of CYP3A4 substrate Details Ribociclib Clindamycin ANTIROBE Explained Increased exposure of CYP3A4 substrate and an increased risk of CYP3A4 substrate-related adverse reactions Details Ribociclib Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Ribociclib Sertraline Explained An increased risk of QT interval prolongation Details Ribociclib Buprenorphine Belbuca Explained An increased risk of QT interval prolongation, increased buprenorphine exposure and an increased risk of buprenorphine-related adv... Details Ribociclib Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Ribociclib Abemaciclib Verzenio Explained Increased exposure of CYP3A4 substrate and an increased risk of CYP3A4 substrate-related adverse reactions Details Ribociclib Acalabrutinib Calquence Increased exposure of CYP3A4 substrate and an increased risk of CYP3A4 substrate-related adverse reactions Details Ribociclib Ado-Trastuzumab Emtansine Injection KADCYLA Increased exposure of cytotoxic component DM1 (maytansine derivative) and risk of toxicity Details Ribociclib Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Ribociclib Apixaban Eliquis Explained Increased apixaban exposure Details Ribociclib Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Ribociclib Aripiprazole Injection Abilify Increased ARIPiprazole exposure and an increased risk of QT interval prolongation Details Ribociclib Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Ribociclib Asciminib Scemblix Increased asciminib exposure, increased CYP3A4 substrate exposure, increased risk of asciminib-related adverse effects and an incr... Details Ribociclib Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Ribociclib Atogepant Qulipta Increased atogepant exposure Details Ribociclib Avapritinib Ayvakit Increased avapritinib exposure and increased incidence and severity of adverse reactions Details Ribociclib Azithromycin AzaSite An increased risk of QT interval prolongation Details Ribociclib Cariprazine Vraylar Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Ribociclib Alfuzosin UroXatral An increased risk of QT interval prolongation Details Ribociclib Amlodipine Amvaz® Increased amLODIPine exposure and an increased risk of hypotension and edema Details Ribociclib Anagrelide Agrylin An increased risk of QT interval prolongation Details Ribociclib Axitinib Inlyta Increased exposure of CYP3A4 substrate and an increased risk of CYP3A4 substrate-related adverse reactions Details Ribociclib Beclomethasone Nasal Spray Beconase Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Ribociclib Beclomethasone Oral Inhalation Beclovent® Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Ribociclib Bedaquiline Sirturo Increased bedaquiline exposure and an increased risk of QT interval prolongation Details Ribociclib Bosutinib Bosulif Increased bosutinib exposure Details Ribociclib Brexpiprazole Rexulti Increased brexpiprazole exposure Details Ribociclib Brigatinib Alunbrig Increased exposure of CYP3A4 substrate and an increased risk of CYP3A4 substrate-related adverse reactions Details Ribociclib Budesonide Entocort Increased budesonide exposure Details Ribociclib Budesonide Nasal Spray Rhinocort Increased budesonide exposure Details Ribociclib Budesonide Oral Inhalation Pulmicort Increased budesonide exposure Details Ribociclib Cabazitaxel Injection Jevtana Increased cabazitaxel exposure Details Ribociclib Cabozantinib Cabometyx Increased cabozantinib exposure and an increased risk of cabozantinib-related adverse reactions Details Ribociclib Cabozantinib (Thyroid Cancer) Cabometyx Increased cabozantinib exposure and an increased risk of cabozantinib-related adverse reactions Details Ribociclib Calcifediol Rayaldee Altered serum levels of calcifediol Details Ribociclib Chloroquine Aralen® An increased risk of QT interval prolongation Details Ribociclib Clindamycin Injection ANTIROBE Increased exposure of CYP3A4 substrate and an increased risk of CYP3A4 substrate-related adverse reactions Details